Integra LifeSciencesIART

那斯達克 · USD
11.91
-0.42
(-3.37%)
收盤 10/24 03:59 (UTC+8)
10/24 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 4.18
  • 3.81
  • 4.43
  • 3.83
  • 4.16
  • 4.02
  • 4.35
  • 3.92
  • 4.19
  • 4.11
icon
  • 13.37
  • -8.93
  • 16.23
  • -13.55
  • 8.61
  • -3.26
  • 8.17
  • -9.89
  • 6.85
  • -1.81
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
營業收入淨額
411,182
418,761
391,918
434,925
402,062
415,605
382,653
442,646
380,834
418,175
營業成本
-199,017174,936214,060195,071206,273188,221193,574180,596192,258
營業毛利
-
219,744
216,982
220,865
206,991
209,332
194,432
249,072
200,238
225,917
營業費用
-200,459205,512197,825195,230722,006----
研發費用
-24,25323,50124,79022,45626,99724,72831,21027,43529,767
推銷及管理費用
-172,436178,235169,267169,046179,890181,497178,520177,193195,472
非經常性項目費用
-----511,365----
其他營業費用
-3,7703,7763,7683,7283,7543,7043,7153,7613,707
營業利益
18,900
19,285
11,470
23,040
11,761
-512,674
-15,497
35,627
-8,151
-3,029
其他收入及費用
-8,4518,5864,9434,1402,7644,2765,8987,1616,495
利息費用
-22,99422,46523,67322,72521,04218,81518,98419,37318,651
稅前純益
15,664
4,742
-2,409
4,310
-6,824
-530,952
-30,036
22,541
-20,363
-15,185
所得稅
8122592,2086,014-1,420-46,879-4,7433,106-9,667-2,783
稅後純益
14,852
4,483
-4,617
-1,704
-5,404
-484,073
-25,293
19,435
-10,696
-12,402
基本每股稅後盈餘(元)
0.190.06-0.06-0.02-0.07-6.21-0.330.25-0.14-0.16
稀釋每股稅後盈餘(元)
0.190.06-0.06-0.02-0.07-6.32-0.330.25-0.14-0.16
基本平均股數(千股)
77387.0077779.0076951.0077887.0076753.0077921.0077712.0077164.0077134.0077583.00
稀釋平均股數(千股)
78577.0078168.0076951.0077887.0077200.0077921.0077712.0077164.0077134.0077583.00
還原基本每股稅後盈餘(元)
0.190.06-0.06-0.02-0.07-6.21-0.330.25-0.14-0.16
還原稀釋每股稅後盈餘(元)
0.190.06-0.06-0.02-0.07-6.32-0.330.25-0.14-0.16
還原基本平均股數(千股)
77,38777,77976,95177,88776,75377,92177,71277,16477,13477,583
還原稀釋平均股數(千股)
78,57778,16876,95177,88777,20077,92177,71277,16477,13477,583
EBITDA(千元)
15,66466,89159,48167,42855,738-470,32827,35280,51436,30641,703

大家都在看

HOT